http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-015909-B9

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dfae81468523c4a7e635145a1bfe2359
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1623
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-216
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-222
filingDate 2007-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a20b0db47045642c5057550f4a2a38a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13505adef5b3949ba8ad5fdc9cb3ec42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35b66ff9fc8e1c26042d1727d95d15dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5632d225fbdcdc110e04d18e192fb094
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36514cc4e8504543730bfe1bea1ea35b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6db04264ecd03e573c39063cb079567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d0e703330e1cb516a5b64559b07fdc7
publicationDate 2012-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EA-015909-B9
titleOfInvention STABILIZED PHARMACEUTICAL COMPOSITIONS CONTAINING PHESTERODINE
abstract The invention relates to a pharmaceutical composition comprising fesoterodine or its pharmaceutically acceptable salt or solvate and a stabilizer selected from the group consisting of xylitol, sorbitol, polydextrose, isomalt and dextrose.
priorityDate 2006-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03099268-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9944604-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0135957-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82170
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID88735
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6912
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419479800
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419489866
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419585166
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490943
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918558
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5780

Total number of triples: 42.